FIELD: medicine, psychiatry, pharmacology.
SUBSTANCE: invention proposes applying one or some compounds from the group consisting of smilagenin, praserigenin, astragaloside, tigogenin, ruscogenin, hecogenin and diosgenin as the preparation for treatment the state characterizing with insufficiency of number or function of post-synaptic membrane-bound receptors, namely for treatment of disorders associated with the cognitive ability.
EFFECT: expanded assortment of agent used in psychiatry, valuable medicinal properties of agents.
29 cl, 5 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STEROID SAPOGENINS AND THEIR DERIVATIVES USABLE IN MEDICAL TREATMENT | 2004 |
|
RU2297228C2 |
| DERIVATIVES OF 5B-SAPOGENIN AND PSEUDO SAPOGENIN AND APPLICATION FOR DEMENTIA MEDICAL TREATMENT | 2000 |
|
RU2325396C2 |
| DERIVATIVES OF SAPOGENIN, THEIR SYNTHESIS, USING AND METHOD BASED ON THEIR USING | 2002 |
|
RU2311423C2 |
| DERIVATIVES OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL AGENTS BASED ON THEREOF | 1999 |
|
RU2278111C2 |
| APPLICATION OF 10-[(3R)-1-AZABICYCLO[2,2,2]OCT-3-YLMETHTYL]-10H-PHENOTHIAZINE FOR PREPARING DRUG SELECTIVELY INHIBITING MUSCARINE RECEPTORS M1L, M2 AND M3 | 2007 |
|
RU2449794C2 |
| DERIVATIVES OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1999 |
|
RU2230740C2 |
| APPLICATION OF N-DISMETILKLOSAPINE FOR HUMAN NEUROPSYCHIATRIC DISEASES TREATMENT | 2004 |
|
RU2336879C2 |
| TREATMENT OF OVERACTIVE BLADDER SYNDROME | 2022 |
|
RU2792534C1 |
| 1,3,5-TRISUBSTITUTED TRIAZOLE DERIVATIVE | 2008 |
|
RU2476433C2 |
| TRISUBSTITUTED 1,2,4-TRIAZOLES | 2008 |
|
RU2474579C2 |
